BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

China Clears Adcentrx’s ADRX 0405 For Clinical Development In Advanced Solid Tumours

Follows initiation of Phase 1a/1b study in the U.S. Adcentrx intends to include clinical centers in China to broaden geographic repr...

June 10, 2026 | News

Waters Launches Industry First RP Column Platform To Accelerate GLP 1 And LNP Drug Development

Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottleneck...

June 10, 2026 | News

Everest Medicines Acquires Greater China Rights to Presbyopia Therapy LNZ100

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

June 09, 2026 | News

Vcare PharmaTech Secures China Approval for Next Generation TRK Inhibitor Eratrectinib in NTRK Fusion Positive Solid Tumours

NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the...

June 08, 2026 | News

Travere Secures Global Rights to Civorebrutinib in $1.14 Billion Kidney Disease Partnership with Everest Medicines

Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immun...

June 04, 2026 | News

Ginkgo Datapoints, Tangible Scientific and Inductive Bio Launch ADME One to Accelerate Early Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projec...

June 03, 2026 | News

Scientific Infrastructure or Expensive Theatre? AI Discovery’s Reckoning in Asia

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” ...

June 02, 2026 | Analysis

XtalPi Earns Second Milestone Payment As AI Drug Discovery Alliance With DoveTree Gains Momentum

XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical c...

June 02, 2026 | News

Lilly Secures Global Rights To Hanmi's Sonefpeglutide In Potential $1.26 Billion Deal

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications Hanmi Pharm. Co., Ltd. ("Hanmi") announced that they have entered i...

June 02, 2026 | News

China Developed Anaesthetic Cipepofol Secures US FDA Approval, Marking Global Breakthrough

Cipepofol (CYPSEDO) Injection (hereinafter "Cipepofol"), a Class 1 innovative intravenous anesthetic independently developed by Haisco Pharmaceutical ...

June 02, 2026 | News

Syncell Launches Global Discovery Services To Accelerate Biomarker And Drug Target Identification

Global program expands access to unbiased nanoscopic proteomic technology to accelerate biomarker identification and drug target discovery -Syncel...

June 01, 2026 | News

Leica Biosystems, Indica Labs, And Lunit Advance AI Powered Digital Pathology For PD L1 Biomarker Analysis

Building on the market-defining computational pathology partnership between Leica Biosystems and Indica Labs, this new collaboration integrates Lunit's adv...

May 29, 2026 | News

CGBIO Expands Global NOVOSIS Partnership With DePuy Synthes Into North America And Australia

DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development...

May 28, 2026 | News

Insilico Medicine And HLFM Launch AI Collaboration To Advance Human Longevity Science

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Human Life Foundation M...

May 28, 2026 | News

Stay Connected